INTRODUCTION
============

Phosphorylation is a widespread form of posttranslational protein modification; the most comprehensive study to date estimates that over 75% of human proteins are phosphorylated ([@B47]). Cells from a wide variety of biological states have been found to share many phosphorylation events, but 20% are found exclusively in mitotic cells, which also contain some of the highest stoichiometry of sites ([@B47]).

In yeast cells, there are a single cyclin-dependent kinase (Cdk1/Cdc28) and nine cyclins that regulate its activity toward particular targets, thereby advancing the cell cycle through G1-S-G2-M ([@B34]). In addition, Mps1 kinase and Cdc5 polo kinase have been shown to be required for cell cycle progression ([@B56]; [@B45]; [@B17]; [@B7]). Like DNA duplication, duplication of the SPB is a highly regulated cell cycle event necessary for chromosome segregation in mitosis. Although SPBs are structurally distinct from centrosomes, study of SPB duplication and spindle formation has led to insights into mechanisms of spindle assembly, microtubule nucleation, asymmetric cell division, and spindle positioning relevant to higher organisms ([@B12]).

In budding yeast, the nuclear envelope stays intact throughout the cell cycle and the SPB remains embedded in the nuclear envelope, nucleating both cytoplasmic and nuclear microtubules. All of the components of the SPB have been identified, and much has been established about the interaction and function of the various proteins through a number of techniques, including two-hybrid analysis, Förster resonance energy transfer (FRET), and genetics. Recently, a model of the molecular architecture of the SPB core was determined using integrative structure modeling incorporating the large volume of data known about the SPB ([@B53]). The steps of SPB duplication also have been well described (reviewed in [@B41]; [@B12]) using both electron microscopy ([@B9], [@B10]; [@B1]) and high-resolution fluorescence techniques revealing the order of addition of particular components ([@B8]; [@B46]; [@B40]). SPB duplication entails elongation of the "half-bridge" (see pathway in [Figure 9](#F9){ref-type="fig"} later in this paper), deposition of a "satellite," starting with Spc42 quickly followed by Spc29, and maturation into a duplicate plaque, which becomes the new SPB. A Bbp1--Mps2 complex is thought to aid insertion of the duplicate plaque into the nuclear envelope ([@B43]). Mutations that block this step ([@B56]) result in a detached pole (sometimes referred to as a "dead pole"; [@B4]) that can separate from the mother SPB and remains associated with, but does not insert into, the nuclear envelope. Interestingly, duplication plaque insertion also involves clustering of nuclear pore complexes and additional membrane-bound proteins, as well as interaction of the new SPB core with nuclear Spc110 ([@B40]). Next the core SPB-Spc110 connects the nuclear gamma tubulin complex, initiating nucleation of microtubules ([@B8]; [@B40]), and the duplicated SPBs separate to opposite sides of the nucleus, leading to the formation of a bipolar spindle. Errors at any step of SPB duplication result in activation of the spindle checkpoint, which transiently delays the cell cycle in an attempt to correct the spindle assembly defect (as reviewed in [@B2]).

The restriction of duplication to once per cell cycle is accomplished by an elegant mechanism involving, in part, phosphorylation/dephosphorylation of the conserved Sfi1 protein, which is a structural component of the half-bridge ([@B5]; [@B17]). Phosphorylation of two core central plaque components of the SPB, Spc42 and Spc29, has also been investigated. Proper Spc42 assembly at the SPB and normal spindle function require two verified Cdk1 sites (Spc42-S4T6) as well as Mps1 activity ([@B11]; [@B24]). Spc29 also has been shown to be phosphorylated by both Cdk1 and Mps1, and several Mps1 sites have been mapped in Spc29 ([@B21]; [@B3]). The mutation *spc29-T240A* (as well as a mutation changing all of the mapped Mps1 sites to alanines) is lethal in single copy ([@B21]; [@B3]), and two copies of T240A in tandem lead to a monopolar spindle phenotype at the nonpermissive temperature ([@B21]). Spc29 has been shown to bind Bbp1 ([@B43]), and Spc29 phosphorylation increases binding ([@B3]). Furthermore, biochemical studies have provided reconstitution of an Spc29-Bbp1-Mps2 complex ([@B28]).

Despite analysis of Spc29 phosphorylation, studies investigating effects on specific protein--protein interactions have involved alleles with multiple mutations; thus, the mechanism of action of single essential phosphorylation events remains to be elucidated. Also, many of the sites in both Spc29 and Spc42 identified in the phosphoproteomic analysis of the SPB ([@B25]) have not been investigated. To determine how modification of both known sites and these additional residues influences SPB duplication and spindle assembly, we describe a comprehensive analysis of the role of phosphorylation in the SPB core components Spc29 and Spc42, examining effects on cell growth, cell cycle progression, SPB duplication, mitotic spindle morphology, protein localization, and protein--protein interactions. Our work provides insight into the mechanism by which particular phosphorylation events influence distinct steps in this complex pathway.

RESULTS
=======

Phosphosite analysis
--------------------

We previously performed a phosphoproteome analysis of the *Saccharomyces cerevisiae* centrosome ([@B25]). This work identified 297 (227 novel) phosphorylated residues on the 18 known SPB components in enriched SPB preparations analyzed by mass spectrometry. Twenty-one percent of these (65 sites) were found on the core SPB binding partners, Spc29 and Spc42. In the current study, we performed a comprehensive mutagenic analysis in the W303 yeast strain of all serine/threonine residues in Spc29 and Spc42 found in our previous work (or another, [@B24]) to be phosphorylated in vivo. See [Table 2](#T2){ref-type="table"} later in the paper for a summary of their relative growth rates.

Mutation of phosphorylated residues in Cdk1 sites is exacerbated in the presence of mps1 mutations
--------------------------------------------------------------------------------------------------

Spc29 has been shown to be phosphorylated in vivo on four serines lying within Cdk1 (S/T(P)) motifs ([@B20]; [@B25]). Mutation of all four residues to alanine (*spc29-Cdk-4A,* S59A, S65A, S77A, S121A; [Table 1](#T1){ref-type="table"}) does not result in a growth defect at any temperature checked ([Figure 1](#F1){ref-type="fig"}, A and C). Because SPB components have been shown previously to be regulated by both Cdk1 and Mps1, we examined the effect of this mutation in the presence of a unique *MPS1* mutation, *mps1-8*, that is defective in its SPB duplication function but not in its checkpoint function ([@B11]). If the cells also contain *mps1-8*, there is an additive cost to fitness, decreasing growth at 30°C ∼25-fold compared with that for *mps1-8* alone. Mutation of the same residues to aspartic acid also led to reduced growth in the presence of *mps1-8*. Using the combined defects of *spc29-Cdk-4A* and *mps1-8*, we were able to determine the relative contribution of each site and show that *spc29-S121A* is the most significant mutation of the 4A allele ([Figure 1](#F1){ref-type="fig"}, B and C). This may be due to the fact that S121 is the only one of the four that contains a full Cdk1 motif (S/T-P-X-K/R), which has been shown to be phosphorylated more efficiently than the minimal (S/T-P) sites ([@B26]).

###### 

Changed amino acid residues in mutant alleles.

  Allele         Mutations                                                                   
  -------------- ----------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  Spc29-30A      S9A         S11A    S39A    S40A    T42A    S43A    S58A    S59A    S65A    T67A
                 S70A        S77A    S100A   T107A   T119A   S120A   T125A   S130A   S167A   S187A
                 S189A       S191A   T195A   S216A   S217A   S230A   S231A   S239A   S249A   S250A
  Spc42-24A      S12A        S29A    S43A    T59A    S130A   T131A   S151A   T168A   T193A   S195A
                 S204A       T221A   S246A   S255A   S284A   S294A   S308A   S319A   S321A   S322A
                 S328A       S329A   S352A   T354A                                           
  Spc29-Cdk-4A   S59A        S65A    S77A    S121A                                           
  Spc29-Cdk-4D   S59D        S65D    S77D    S121D                                           
  Spc42-Cdk-8A   S4A         S6A     T32A    S213A   S217A   S326A   T357A   T359A           

![The mutation in a Cdk1 motif, *spc29-S121A*, confers a growth defect in the presence of *mps1-8*. (A) Diagram of Spc29 showing position of "4A" and "4D" phosphorylation site mutations (asterisks) and the predicted coiled--coil domain from residues 16--36 (shaded box). spc29-Cdk-4A = spc29-S59A, S65A, S77A, S121A; spc29-Cdk-4D = spc29-S59D, S65D, S77D, S121D. Growth of cells with listed genotypes at 24, 30, and 37°C for 2 d. There are two rows each for *spc29-4A;mps1-8* and *spc29-4D;mps1-8*. (B) Growth of cells with listed genotypes at 24 and 30°C for 3 d. (C) Summary of growth of strains. Numbers indicate estimated percent growth compared with wild-type strain, based on a fivefold dilution assay.](mbc-29-2280-g001){#F1}

We previously reported that a mutation to alanine in all eight potential Cdk1 sites in Spc42 is lethal and has reduced SPB localization ("8A"; [@B25]). Further examination of this allele revealed that it also contained a single nucleotide deletion at position 37 in the coding sequence. Therefore, the *spc42-Cdk-8A* allele (residues S4, T6, T32, S213, S217, S326, T357, T359; [Table 1](#T1){ref-type="table"}) was remade and tested in our dilution assay and also fused to GFP (green fluorescent protein) to monitor localization. *Spc42-Cdk-8A* leads to a decrease in growth compared with the wild type ([Figure 2](#F2){ref-type="fig"}A and [Table 2](#T2){ref-type="table"}) and an ∼25-fold decrease at 37°C. Residues S4, T6, T357, and T359 are the S/T(P) sites conserved among budding yeasts in Spc42 (Supplemental Figure 1A; note location of black stars above the sequence to mark sites). *Spc42-Cdk-8A* cells are more defective in the presence of the checkpoint mutation *mad2∆* (37°C, see [Figure 4](#F4){ref-type="fig"}B, later in the paper, for growth of *SPC42;mad2∆*) or with *mps1-8* (24°C). Also, *spc42-Cdk-8A;spc29-Cdk-4A* growth is slightly more reduced at 37°C than for either alone, and the *spc42-8A;spc29-4A;mps1-8* allele is dead (see [Figure 1](#F1){ref-type="fig"}A for growth of *spc29-Cdk-4A*). Both Spc42-GFP and Spc42-Cdk-8A-GFP localize as one or two foci (depending on cell cycle stage), consistent with normal SPB localization ([Figure 2](#F2){ref-type="fig"}B), and showing that the mutation does not dramatically affect Spc42 levels. Taken together, these data suggest that phosphorylation due to the Mps1 and Cdk1-Cdc28 protein kinases is required directly or indirectly for full function of both Spc29 and Spc42. Because Spc42 is known to interact with both Spc29 and the C-terminus of Spc110 ([@B1]; [@B16]), we tested whether the *spc42-Cdk-8A* mutation affected interactions with these binding partners in a yeast two-hybrid assay. Wildtype Spc42 interacts with itself, Spc29, and the C-terminus of Spc110, as previously reported ([@B1]; [@B16]). We demonstrate that Spc42-Cdk-8A is able to interact with Spc42 and with Spc29 but not with the C-terminus of Spc110 ([Figure 2](#F2){ref-type="fig"}C), suggesting that phosphorylation is important for the Spc42-Spc110 interaction.

![Mutations in Spc42 sites lying in Cdk1 motifs impair interaction with Spc110 and cause growth defects that are exacerbated by an SPB-defective mutant in MPS1, but do not impair localization. (A) Diagram of Spc42 showing position of spc42-Cdk-8A phosphorylation site mutations (asterisks) and the predicted coiled--coil domains from residues 62--131 and 251--278 (shaded boxes). spc42-Cdk-8A = S4A, T6A, T32A, S213A, S217A, S326A, T357A, T359A. Growth of cells with listed genotypes at 24 and 37°C for 1 d. (B) Localization of Spc42-GFP and Spc42-Cdk8A-GFP at 24°C. Cells are imaged with DIC, and green is GFP autofluorescence. (C) Two-hybrid analysis on -His plates of interactions between Spc42, Spc42-Cdk-8A, and Spc42-24A with Spc42, Spc29, and the carboxy terminus of Spc110 (from 741-944, "Spc110-C").](mbc-29-2280-g002){#F2}

###### 

Estimated growth (%) for *SPC29* and *SPC42* alleles (W303 strain).

  Mutant strain                      24°C   24°C *mad2∆*   37°C   37°C *mad2∆*   Reference
  ---------------------------------- ------ -------------- ------ -------------- ---------------
  *SPC29-wildtype (integ)*           100    100            100    100            This study
  *spc29-T240A*                      ---    nd             ---    nd             [@B21], [@B3]
  *spc29-T240A (2 tandem copies)*    100    nd             ---    nd             [@B21]
  *spc29-T18A*                       20     0.2            ---    ---            This study^a^
  *spc29-T18D*                       100    nd             100    nd             This study^a^
  *spc29-30A*                        100    100            100    100            This study
  *spc29-4A*                         100    nd             100    nd             This study
  *SPC42-wildtype (integ)*           100    100            100    100            This study
  *spc42-24A*                        100    100            4      ---            This study
  *Spc29-wildtype; Spc42-wildtype*   100    100            100    100            This study
  *spc29-30A; spc42-24A*             100    100            0.2    ---            This study
  *mps1-8*                           100    nd             ---    nd             [@B11]
  *spc42-Cdk-8A*                     20     20             4      0.8            This study^b^
  *spc42-Cdk-8A; mps1-8*             4      nd             ---    nd             This study
  *spc29-Cdk-4A; spc42-Cdk-8A*       100    nd             20     nd             This study

nd = not determined; --- = dead.

^a^These effects are more severe in strain S288C ([@B3]).

^b^Mutation *spc42-Cdk-8A* was remade; in [@B25], an additional mutation was present.

Additional phosphorylation events are required for robust spindle formation
---------------------------------------------------------------------------

Next, we focused on mutations of the non-Cdk1 sites in both Spc42 and Spc29. Except for *spc29-T18A* and *spc29-T240A*, other single residue alanine mutations did not result in an apparent fitness defect (see *Materials and Methods* for comparison with [@B3]). We found that in comparison with the wild type, cells containing the *spc29-T18A* mutation showed impaired growth (24°C and 30°C), were both cold (16°C)- and heat (37°C)-sensitive, and were more compromised in the presence of *mad2∆* ([Figure 3](#F3){ref-type="fig"}A and [Table 2](#T2){ref-type="table"}). In addition, we show that haploid *spc29-T18A* cells quickly become apparent diploids (Supplemental Figure 2A), a phenotype observed for mutations in a subset of SPB genes: *CDC31*, *MPS2*, *KAR1*, *NDC1*, and *MPS3*, although the mechanism is not fully elucidated ([@B42]; [@B56]; [@B52]; [@B13]; [@B23]). Spc29-T18A-GFP localizes as one or two foci ([Figure 3](#F3){ref-type="fig"}B, 24 and 37°C), suggesting that the lethality caused by *spc29-T18A* at 37°C is not due to mislocalization. Interestingly, Spc29 functions like the wild type when T18 is mutated to a phosphomimic aspartic acid residue, bolstering the importance of its role as a phosphorylated residue ([Figure 3](#F3){ref-type="fig"}A and [Table 2](#T2){ref-type="table"}). Both T18 and the other important Mps1 site, T240, lie in the most conserved regions of Spc29 among budding yeasts (Supplemental Figure 1B, Spc29; note location of black stars above the sequence to mark sites).

![*spc29-T18A* confers a growth defect but does not impair SPB localization. (A) *spc29-T18A* cells show growth defects and are both cold- and heat-sensitive. Diagram of Spc29 showing the position of T18A phosphorylation site mutation (asterisk) and the predicted coiled--coil domain from residues 16--36 (shaded box). Growth of cells with listed genotypes (top four panels, 24, 30, 16, and 37°C): 2 d, bottom two panels (24 and 30°C): 3 d in *mad2∆* background (\*). (B) Localization of Spc29-GFP-WT and Spc29-T18A-GFP at 24 and 37°C Far right panel growth was at 37°C; left and middle panels were at 24°C. Cells are imaged with DIC, and green is GFP autofluorescence.](mbc-29-2280-g003){#F3}

The lack of an observable growth defect in other single-residue substitution mutants could be due to the highly redundant nature of many posttranslational modifications. Therefore, we mutated the remaining in vivo sites as a group to create *spc29-30A* and *spc42-24A*, in which 30 and 24 positions in the respective proteins were mutated to alanine ([Table 1](#T1){ref-type="table"}). We included mutations in the minimal Cdk motifs in the *SPC29* allele because they did not show any growth defects either on their own, or with *mps1-8*. Surprisingly, this extensive mutagenesis (12% of Spc29; 7% of Spc42) of either gene alone or combined in the same cell (*spc29-30A;spc42-24A*) results in functional proteins that support growth ([Figure 4](#F4){ref-type="fig"}, A and C, 24°C, and [Table 2](#T2){ref-type="table"}) and localize to the SPB ([Figure 4](#F4){ref-type="fig"}D). In addition, the levels of these altered Spc29 and Spc42 proteins are not dramatically different from those in the wild-type versions (see [Figures 3](#F3){ref-type="fig"} and [2](#F2){ref-type="fig"}, respectively). Consistent with this fitness level, analysis of the propensity to form coiled coils reveals that neither Spc29 nor Spc42 shows dramatic differences in these heavily altered proteins (Supplemental Figure 3; [@B31]). However, at elevated temperatures*, spc42-24A* cells grow less than the wild type and are dead with *mad2∆* ([Figure 4](#F4){ref-type="fig"}B, 37°C, and [Table 2](#T2){ref-type="table"}); additionally, in a yeast two-hybrid system, Spc42-24A shows reduced interaction with the C-terminus of Spc110 ([Figure 2](#F2){ref-type="fig"}C). The double mutant (*spc29-30A; spc42-24A*) is severely impaired and dead in the presence of *mad2∆* at 37°C ([Figure 4](#F4){ref-type="fig"}C and [Table 2](#T2){ref-type="table"}). Interestingly, under lethal conditions, at 37°C in the presence of *spc42-24A*, the majority of Spc29-30A-GFP is still able to localize to the SPB ([Figure 4](#F4){ref-type="fig"}D), although there is some additional diffuse signal not at the SPB in about a third of the cells (see the inset).

![A double mutant of *SPC29* and *SPC42* is lethal at 37°C but does not impair SPB localization. (A) Growth of cells with listed genotypes and otherwise wildtype backgrounds at 24, 30, and 37°C for 3 d. (B) Growth of cells with listed genotypes in a *mad2∆* background (\*) for 3 d. (C) Growth of double integrated wild-type or mutant cells at 24 and 37°C with otherwise wild-type or *mad2∆* (\*) background for 3 d. (D) Localization of Spc42-24A-GFP and localization of Spc29-30A-GFP both in an otherwise wild-type background and in cells also containing spc42-24A (\*). Growth in bottom right panels was at 37°C; all others at 24°C. An additional aberrant signal of Spc29-30A was observed in 38% of *spc42-24A* cells at 37°C (inset, bottom right), *n* = 50. Cells are imaged with DIC and green is GFP fluorescence.](mbc-29-2280-g004){#F4}

To understand the defect conferred by the double mutation at 37°C, we analyzed DNA content in wild-type and *spc29-30A; spc42-24A* cells before and after the shift to 37°C, and cell morphology at 37°C. Compared with wild-type cells, the double mutant cells display a mitotic delay after the shift, indicated by an increase of cells with high G2-M DNA content and large buds (Supplemental Figure 4, A and B). Immunofluorescence shows that after the shift to 37°C, the large-budded *spc29-30A; spc42-24A* cells contained mostly short spindles (∼60%) but also single microtubule asters (with an unduplicated or two closely spaced SPBs, 25%) and elongated spindles (15%), while cells containing the integrated wild-type alleles contained a mix of short and long spindles ([Figure 5](#F5){ref-type="fig"}). The pleiotropic effects of this double mutant allele suggests that these sites are not required for a specific step in SPB duplication or spindle formation. Further, our results imply that there is considerable plasticity or redundancy within the core SPB to accommodate large changes in amino acid sequence, as in Spc29-30A and Spc42-24A.

![Mutation of multiple phosphorylation sites in Spc29 and Spc42 leads to SPB/spindle defects at several stages in mitosis. Immunofluorescence of cells containing either integrated wild-type alleles of *SPC29* and *SPC42* (SPC29;SPC42) or *spc29-30A* and *spc42-24A* alleles (spc29-30A;spc42-24A) grown for 6 h at 37°C. Bar = 2 μm. Blue = DNA (DAPI); red = SPB (Tub4); green = tubulin (Tub1). Below, different spindle phenotypes are quantified for SPC29;SPC42 (*n* = 100) or spc29-30A;spc42-24A (*n* = 134). MT = microtubule.](mbc-29-2280-g005){#F5}

Phosphorylation of Spc29-T18 and of Spc29-T240 have distinct roles in SPB function
----------------------------------------------------------------------------------

Because of the severe growth defect resulting from the point mutation *spc29-T18A*, we were interested in examining its effect on the SPB cycle. *spc29-T18A* cells were synchronized in G1 and released to 37°C, and then analyzed for DNA content and cell morphology to check cell cycle progression and subjected to immunofluorescence to examine the spindle and SPBs. Unlike wild-type cells, which are mostly small-budded and have approximately equal amounts of G1 and G2/M DNA content after a shift to 37°C, most *spc29-T18A* cells are large-budded and have G2/M DNA content, indicating a mitotic delay (Supplemental Figure 2, B and C, 37°C). Immunofluorescence analysis demonstrates that the majority of wild-type large-budded cells contain duplicated SPBs, an extended anaphase spindle, and separated DNA masses ([Figure 6](#F6){ref-type="fig"}). In contrast, while all *spc29-T18A* large-budded cells appear to have duplicated SPBs, most have short spindles with a single DNA mass, and a subset (14%) contain a detached SPB that is not associated with microtubules or the DNA staining inside the nucleus ([Figure 6](#F6){ref-type="fig"}, white arrowheads). The observed diploidization in *spc29-T18A* cells likely results from large-budded cells that contain short spindles and DNA only in one bud (inappropriate for this late stage) that undergo cytokinesis, resulting in a diploid and an aploid cell.

![The *spc29-T18A* mutation causes defects in spindle elongation and in SPB insertion in a subset of cells. Immunofluorescence of *SPC29* and *spc29-T18A* cells shifted from 24°C α-factor arrest to 37°C for 3 h: left panels, DIC/DAP1 (blue); right panels, tubulin (green), Tub4/SPB (red). Arrowheads in right bottom panel and inset show detached poles. Bar = 2 μm. Below, spindle phenotypes are quantified: *SPC29* (*n* = 100) and *spc29-T18A* (*n* = 190).](mbc-29-2280-g006){#F6}

To examine whether the structure and position of the new SPB were altered in *spc29-T18A* cells, we examined wild-type and *spc29-T18A* cells using serial thin-section electron microscopy. Wild-type (*SPC29*) cells displayed normal bipolar spindle assembly and SPB morphology, with both SPBs embedded in the nuclear envelope, facing toward each other in proper orientation to nucleate interdigitated microtubules ([Figure 7](#F7){ref-type="fig"}A, black arrows and insets, *n* = 8). In contrast, over half of the *spc29-T18A* cells (*n* = 20) displayed dramatic defects with respect to bipolar spindle assembly and positioning of SPBs. The defects included abnormal positioning of SPBs in anaphase ([Figure 7](#F7){ref-type="fig"}B, class I, *n* = 3), an early block to insertion of the duplication plaque ([Figure 7](#F7){ref-type="fig"}B, class II, *n* = 4), and invagination of SPBs with large monopolar spindles ([Figure 7](#F7){ref-type="fig"}B, class III, *n* = 5). In the first class of *spc29-T18A* cells, the aberrant pole in *spc29-T18A* cells ([Figure 7](#F7){ref-type="fig"}B, class I, bottom inset) does not appear to be correctly inserted into the nuclear envelope. Also, the mother SPB and the daughter SPB are not facing each other; the lower SPB is in longitudinal view and the upper SPB is en face so that only the microtubules in cross-section are visible ([Figure 7](#F7){ref-type="fig"}B, class I, top inset). The upper "active" SPB in the *spc29-T18A* class I cell appears to be nucleating more microtubules than is normal for a wild-type SPB in late anaphase (wild-type cells have 16 kinetochore and four polar microtubules for ∼20 total), consistent with a delay in mitosis ([@B39]). We used electron tomography to image the details of spindle structure of five large-budded *spc29-T18A* cells. Two cells showed large monopolar spindles with 63 ([Figure 7](#F7){ref-type="fig"}C, left panel) and 46 microtubules, respectively. Two cells had other spindle defects such as improper bipolar spindle formation and anaphase elongation ([Figure 7](#F7){ref-type="fig"}C, middle and right panels), and one cell appeared to have a normal bipolar spindle. In summary, *spc29-T18A* cells arrest at a nonpermissive temperature with a few long, but mostly short spindles with a variety of defects and a detached pole in a subset of the cells that does not nucleate nuclear microtubules.

![Electron microscopy and electron tomography of *spc29-T18A* cells reveals abnormal SPBs and spindle defects. Line drawings for each panel show the SPB and nuclear envelope. (A) Two sections from the same large-budded wild-type (*SPC29*) cell with a typical anaphase SPB orientation (arrows; insets are higher magnifications of SPBs) with microtubules forming a central spindle (*n* = 8). Bar = 500 nm; insets = 100 nm. (B) Electron microscopy of *spc29-T18A* cells (*n* = 20): Twelve cells were defective and a representative from each of the three classes observed is shown. Class I cells (*n* = 3) display mispositioning of SPBs in anaphase cells. Arrows indicate position of the SPBs; insets show a higher-magnification view. Bar = 500 nm. Class II cells (*n* = 4) display duplication plaque abnormalities such as delayed insertion in large budded cells (arrows; inset is higher magnification of SPB indicated by the arrow). Class III cells (*n* = 5) display invagination of SPBs with monopolar spindles. (C) Electron tomography of *spc29-T18A* cells (*n* = 5). Left: example of a monopolar spindle containing 63 microtubules (green = microtubules; light blue spheres = microtubules plus ends). Middle: bipolar spindle with abnormal SPB positioning. SPBs nucleate 28 and 33 microtubules (green, pink) that do not interdigitate properly. Right: late anaphase spindle contained mostly in the mother cell, resulting in a severely bowed spindle. Bar = 250 nm.](mbc-29-2280-g007){#F7}

We have shown previously that *spc29-T240A* cells have a notably different phenotype than that just described for *spc29-T18A* cells. At a nonpermissive temperature, *spc29-T240A* cells have a complete block in SPB duplication, which results in a single SPB shown by both immunofluorescence and electron microscopy ([@B21]). The *spc29-T18A* defect is also distinct from a quadruple mutant *spc29-T18A,S159A,S187A,T240A*. In the latter case essentially all the cells showed either a single SPB or duplicated SPBs with one detached, resulting in no bipolar spindles ([@B3]).

The observation that mutation of T18 and T240 in Spc29 does not result in the same SPB defect suggests that different steps of duplication, and thus different Spc29 interactions, may be regulated through phosphorylation of each residue. We wondered whether the early defect in SPB duplication in *spc29-T240A* mutant cells could be due to an inability of the mutant to interact either with itself to form multimers, or with other core factors such as Spc42. To test this idea, we examined the interactions of Spc29, Spc29-T18A/D, and Spc29-T240A with Spc29, Spc42, Bbp1, and Spc110, employing the yeast two-hybrid system, which has been used previously to observe interactions between these proteins ([@B16]; [@B43]). We show that none of the altered Spc29 proteins examined, including Spc29-T240A, cause a defect in Spc29--Spc29 interactions ([Figure 8](#F8){ref-type="fig"}A). However, Spc29-T240A, but not Spc29-T18A or D, blocks the interaction between Spc29 and Spc42 ([Figure 8](#F8){ref-type="fig"}B). This is consistent with a failure of *spc29-T240A* cells early in SPB duplication when Spc29 binds Spc42 at the satellite ([@B8]). We next tested interactions with Bbp1 and Spc110, which have both been shown to affect insertion ([@B43]; [@B40]). While wild-type Spc29, Spc29-T18D, and Spc29-T240A are able to interact with Bbp1, Spc29-T18A is defective ([Figure 8](#F8){ref-type="fig"}C). Interaction with Spc110 does not appear to be disrupted by an alanine at position Spc29-T18 (T18A, [Figure 8](#F8){ref-type="fig"}B); however, a phosphomimic aspartate residue (T18D) increases binding. Thus, our two-hybrid analysis reveals that residues Spc29-T18 and Spc29-T240 have disparate effects on binding partners of Spc29. Additional evidence suggesting that *spc29-T18A* may impact interactions with *SPC110* comes from genetic synergism between *spc29-T18A* and two different C-terminal *SPC110* mutations (*spc110-220* and *spc110-226*, [Figure 8](#F8){ref-type="fig"}D; see [Figure 3](#F3){ref-type="fig"}A, 24°C, for *spc29-T18A* alone; [@B51]; [@B50]).

![Spc29-T18A and Spc29-T240A show different defects in interaction with Spc29 binding partners and can complement each other in a diploid. (A--C) Two-hybrid analyses on -His plates. (A) Spc29 and all mutant versions of Spc29 interact with each other robustly (with 30 mM AT). (B) Spc29-T240A disrupts interaction with Spc42 and Spc29-T18D enhances interaction with the carboxy terminus of Spc110 (from 741 to 944, "Spc110-C"). (C) Spc29-T18A disrupts interaction with Bbp1 (with 20 mM AT). (D) Spc29-T18A shows genetic interaction with *spc110-220* and *spc110-226* at 24°C. (E) *spc29-18A* and *spc29-T240A (2 tandem copies)* partially complement each other in a diploid at 37°C.](mbc-29-2280-g008){#F8}

A prediction that stems from the idea that Spc29-T18 and Spc29-T240 have roles in different functions is that the alleles would show genetic complementation. We demonstrate using a functional in vivo test that the temperature-sensitive lethal alleles *spc29-T18A* and *spc29-T240A:(2 tandem copies)* partially complement each other when both are present in a diploid cell ([Figure 8](#F8){ref-type="fig"}E). Collectively, the fact that mutant alleles show diverging SPB duplication defects, different protein interaction preferences, and complementation strongly suggests that these two key Mps1 sites in Spc29 have distinct roles in SPB duplication, with phosphorylation of Spc29-T240 acting earlier and affecting interaction with Spc42, presumably during satellite assembly, and phosphorylation of Spc29-T18 primarily influencing insertion of the duplicated SPB into the nuclear envelope and subsequent spindle elongation. Overall, we have shown that phosphorylation of the SPB core central plaque proteins, Spc29 and Spc42, affects a variety of steps in the pathway from a single SPB to duplicated SPBs that nucleate a bipolar spindle during mitosis.

DISCUSSION
==========

We have completed an extensive mutational analysis of phosphorylation events on the SPB core proteins, Spc29 and Spc42. Three types of mutations were analyzed in Spc29 and Spc42: those in Cdk1 consensus sites (*spc29-121A*, *spc42-Cdk-8A*), those in known Mps1 sites in Spc29 (*spc29-T18A* and *spc29-T240A*), and those in the remaining sites that were identified in the SPB phosphoproteome study (*spc42-24A*, *spc29-30A*; [@B25]). Interestingly, all of the mutations studied that showed growth defects were more deficient at higher temperatures. Temperature-sensitive dysfunction of altered proteins can result from a variety of causes; for example, mutation of buried residues often leads to protein instability due to disruption of protein structure and mutation of surface residues can impair protein--protein (or protein-nucleic acid) interaction ([@B36]; [@B6]). The fact that all our mutant GFP-fusion proteins appear to be sufficiently stable and functional to localize to the SPB suggests that binding, not stability, is the more likely mechanism of temperature sensitivity. Indeed, specific protein--protein interactions were shown to be affected both in the two mutations studied in Spc42 and in the Mps1 site mutations in Spc29. Also, it has been demonstrated previously that phosphorylation can modulate protein binding ([@B58]; [@B38]). However, it is possible that small differences in stability between wild-type and mutant proteins may also contribute to phenotypes. The relatively less severe viability defects observed for mutations than for their defects in the two-hybrid assay (between pairs of proteins) is likely due to the additional stabilizing protein--protein interactions that exist within the context of the entire SPB.

In previous studies, either an *MPS1* mutation or an *spc42-S4AT6A* mutation ([@B11]; [@B24]) leads to aberration in Spc42 assembly using a "super-plaque" assay, in which overexpressed Spc42 has been shown by electron microscopy to lead to an outward expansion of the central plaque beyond the SPB in a layer on the nuclear envelope ([@B14]). We found, however, that mutating more of the Spc42 S/T residues that lie in Cdk1 motifs (Spc42-Cdk-8A) results in growth defects, indicating increased aberrancy either in Spc42 assembly or in another Spc42 function. It should be noted that Spc42-S4 and T6 account for the majority of phosphorylation (\>95%) by Cdk1 in vitro, revealed by comparing a wild-type substrate with one containing these residues changed to alanine ([@B24]). If this is an accurate reflection of in vivo Cdk1 phosphorylation, it implies that the remaining S/T-P sites are either phosphorylated at a much lower stoichiometry or potentially by another proline-directed protein kinase ([@B35]). Further study will be required to clarify the contribution of different proline-directed protein kinases to Spc42 phosphorylation.

Mutation of multiple residues not present in Cdk1 motifs in both Spc29 (*spc29-30A*) and Spc42 (*spc42-24A*) showed surprisingly mild phenotypes at lower temperatures even when combined (*spc29-30A; spc42-24A*) and produced GFP fusion proteins that appeared by autofluorescence to be correctly localized to the SPB. It is possible that during mitosis at permissive temperature, these phosphorylation events provide no advantage to Spc29 and Spc42. However, even when phosphorylation sites are not essential, there is evidence that they may facilitate a switchlike response of a protein ([@B54]), which, in this case, could promote progression through mitosis, particularly noticeable at higher temperatures. Finally, we observed that diploid cells containing *spc42-24A* were unable to produce four-spored asci, pointing to a role for these phosphorylated residues in meiosis (unpublished data), and suggesting that phosphorylation sites may also be conserved for functions other than SPB duplication during vegetative growth ([@B37].

By far the greatest effect of single alanine substitution mutations (nonphosphorylatable) in *SPC29* and *SPC42* is *spc29-T18A* and *spc29-T240A*, which have been shown previously to affect growth ([@B21]; [@B3]). Importantly, we extend this work by showing that these two mutations lead to different defects both in bipolar spindle formation and in binding interactions with Spc42, Bbp1, and Spc110. In addition, the interallelic complementation of the mutations is consistent with each providing the function the other lacks as part of an oligomeric complex, most likely a trimer ([@B59]; [@B53]). Thus our data are consistent with a model where two Mps1 sites on Spc29 play roles in two distinct successive steps in the spindle pole body assembly pathway ([Figure 9](#F9){ref-type="fig"}). First, Mps1 phosphorylates Spc29 at T240, promoting its association with satellite-localized Spc42. Subsequently, Mps1 phosphorylates Spc29 at T18, initiating interaction with the soluble Mps2-binding protein Bbp1and thereby linking the nascent SPB with the nuclear envelope through Mps2 to begin membrane insertion. Next, phosphorylated Spc29 facilitates interaction of the Spc42-Spc29 core with nuclear Spc110 to complete insertion. Interaction of Spc29-T18-P with Spc110 is suggested by both the elevated two-hybrid signal between Spc29-T18D and Spc110 and the genetic synergism combining *spc29-T18A* with either *spc110-220* or *spc110-226*. The more severe genetic combination is with *spc110-220*, which contains a C911R mutation in the Cmd1 binding site; a mutant allele with this same mutation (*spc110-124*; [@B49]) has been shown to reduce binding of Spc110 to Spc29 ([@B16]). FRET analysis of *spc110-226*, on the other hand, shows a decreased signal between Spc110 and Spc42 ([@B57]). Either of these defects could act in combination with *spc29-T18A* mutation to further destabilize interaction of the central plaque with Spc110.

![Model showing role of phosphorylation of Spc29-T18A and Spc29-T240A in sequential steps of SPB duplication. Relevant substructures on the SPB are indicated. Small yellow spheres containing P = phosphorylation events at noted residue. *MPS1* mutations *mps1-8*, *mps1-412*, and *mps1-737* are different mutant alleles with distinct SPB duplication blocks described in the text.](mbc-29-2280-g009){#F9}

Mutations in the protein kinase gene *MPS1* have been shown to result in a variety of defects in the SPB duplication pathway ([@B56]; [@B44]; [@B11]). The mutation *mps1-8* blocks duplication at a very early step before half-bridge elongation ([Figure 9](#F9){ref-type="fig"}). Defects caused by two other *mps1* mutations, both lying in the catalytic domain of Mps1, were found to impede progression on the pathway at different steps, both from each other and from *mps1-8* ([@B44]). While *mps1-412* resulted in a block after half-bridge elongation, *mps1-737* allowed progression through the first step to production of a duplicate plaque that was not inserted into the nuclear envelope. Furthermore, *mps1-737* and *mps1-412* were able to complement each other in a diploid. The fact that Mps1-737 protein has the same or lower in vitro protein kinase activity as Mps1-412 argues against the earlier step simply requiring a lower level of overall kinase activity. A more likely scenario is that *mps1-412* and *mps1-737* negatively affect interactions with substrates that promote satellite formation and duplicate plaque insertion, respectively; while other targets are certainly possible, the C-terminus of Spc29 (at T240) and the N-terminus (at T18) would be excellent candidate substrates for such a mechanism. This mode would be similar to that of Plk4 sequentially phosphorylating Ana2/STIL, first to localize it to the centriole and subsequently to recruit Sas6 ([@B15]).

A recent new study of SPB phosphorylation was conducted ([@B18]), primarily to increase coverage of the gamma-tubulin complex proteins by focusing on a new phosphoproteomic arrest state (G1/S), but it also included SPBs from asynchronous and mitotic cells, as in [@B25]. While, with the use of current analysis methods and more stringent statistical cutoffs, not all of the sites described in ([@B25]) were recovered, the most critical residues described here, Spc29-T18 and T240, as well as all the Cdk sites in both Spc29 and Spc42 (which were covered in their analysis) were shared by the two studies. Furthermore, because only a single new phosphorylated residue in these two proteins (Spc29-Y3 or S4) was identified, the contribution of the vast majority of phosphorylation in Spc29 and Spc42 has been evaluated.

The SPB core architecture model determined by Bayesian integrative structure modeling ([@B53]) contains an interface between a region on Spc110 near its C-terminus, N-terminal Spc42, and Spc29, all three lying just beneath a layer of Cmd1. In the two major clusters of models, Spc29 is elongated and flexible, with the C-terminus likely on the cytoplasmic side. The model was derived in part by FRET and two-hybrid analysis in vivo, which were presumably influenced by the phosphorylation state of the proteins under study. Therefore, it will be interesting to learn in more detail the placement and consequences of individual phosphorylated residues in the multiple interactions between these proteins. Our work is a powerful example of the multilayered control of SPB duplication and serves as a model for analysis of centrosome phosphorylation sites.

MATERIALS AND METHODS
=====================

Strains and plasmids
--------------------

Standard *Escherichia coli* and yeast genetic techniques were used. All yeast strains (Supplemental Table 1) were derived from W303. Null strains were made using a kanMX-marked plasmid ([@B30]) in a PCR for transformation of a diploid wildtype strain. Mutations were made in a modified pRS304-kanMX-(*TRP1*) plasmid ([@B30]) containing either Spc42 or Spc29, either using PCR-directed mutagenesis or synthesized by GenScript (genscript.com). "Wild-type" *SPC29* contained two silent mutations, *Bgl*ll at position +325 and *Nde*1 at position +594 relative to the start of the coding sequence, and *Sma*1 and *Sal*1 restriction sites at positions --9 and +13 relative to the coding sequence, which were used for swapping domains. "Wild-type" *SPC42* contains a silent Sph1 site at nucleotide position +993 relative to the start of the coding sequence and a *Sma*1 site added at position -43 relative to the coding sequence. These "wild-type" plasmids or mutant allele plasmids were integrated into the kanMX locus before sporulation and dissection to obtain the desired haploid mutant strains. All mutant alleles were validated as single-copy in the yeast genome unless otherwise stated. C-terminal tagging of alleles with GFP was done, again using PCR transformation with the haploid mutant strains and selecting for the introduced nutritional marker. Strains were verified by PCR and subsequent sequencing using oligonucleotide primers within the GPF gene and the gene of interest.

Mutant analysis, culture, and cytological techniques
----------------------------------------------------

Mutations were made at two types of sites, those present in potential Cdk1 motifs \[S/T(P)\] and those not in Cdk1 motifs. Most of the changes were to alanine (A), an amino acid that cannot be phosphorylated, and some were to aspartic acid (D), which can act as a phosphomimic in some cases, because of its negative charge. If a growth defect was not detected resulting from the change, mutations were combined with other mutations, either in the same gene or in genes encoding proteins known to interact with or regulate the first protein, such as a mutation in *MPS1*. Because *spc29-T18A* and *spc29-T240A* were already known to cause growth defects ([@B21]; [@B3]), these alleles were not combined with mutations in other residues, but were examined individually. In many cases, mutations were also tested in the presence of a *MAD2* deletion to assess the ability of the strain to grow in the absence of the spindle checkpoint. Growth of strains was measured using fivefold dilution series with cells at an initial OD/ml 0.1 (5 μl on plate) in the leftmost column and fivefold diluted for each successive column. They were grown at the indicated temperatures for the indicated numbers of days. Approximate quantification relative to a wild-type control was as follows: control strains were considered 100% and growth in each successive column to the left was considered fivefold reduced, taking into account the size of the colonies if notably different from the control. Growth experiments were often done in duplicate or with distinct strains containing the identical genotype, and were repeated at least three times for each strain, with highly similar results. Mutations *spc29-T18D* and *spc29-S187A*, which were reported as lethal mutations in previous work ([@B3]), did not show defects in our growth assays. In general, mutations studied in our strain background (W303) cause lesser growth defects than in the strain background (S288C) used in [@B3].

For liquid culture growth, wild-type and mutant cells were grown to log phase at 24°C and either shifted to 37°C or synchronized with alpha factor before release to 37°C for the times indicated. Cells containing *spc29-T18A* increase their ploidy over successive cell cycles; therefore, the strain was covered with a wild-type *SPC29* plasmid, which was selected against just before the experiment. Flow cytometry and budding index analysis were performed to monitor DNA content and cell morphology. For immunofluorescence, samples were fixed with 4% formaldehyde for 1 h, washed with phosphate-buffered saline, treated with zymolyase, and subjected on slides to treatment with YOL1/34 rat anti-tubulin antibody (1/200), FITC anti-rat secondary antibody (1/3000), rabbit anti-Tub4 antibody (1/500), Texas Red anti-rabbit secondary antibody (1/200), and 2-(4-amidinophenyl)-6-indolecarbamidine (DAPI) to detect DNA. In a microscope field, all large-budded cells were counted and at least 100 cells were counted for each condition. Experiments with a particular strain were repeated at least three times with highly similar results. Live cell fluorescence of cells containing GFP-fusion protein was performed on cells from 0.1 to 1 OD/ml, using differential interference contrast (DIC) and FITC channels. Cells appeared uniformly, expressing the GFP fusion, and images were taken to include budded cells. Cells were visualized on an Eclipse Ti inverted microscope (Nikon, Japan) fitted with a CFI PlanApo VC 60× H numerical aperture 1.4 objective (Nikon) and a CoolSNAP hq2 charge coupled device camera (Photometrics) was used. Images were analyzed using MetaMorph Imaging software (Molecular Devices).

Electron microscopy and electron tomography
-------------------------------------------

Cells were prepared for electron microscopy using high-pressure freezing and freeze substitution as previously described ([@B19]). Briefly, cells grown in liquid culture were collected onto a 0.45-μm Millipore filter using vacuum filtration and then high-pressure frozen using a Wohlwend Compact 02 high-pressure freezer (Technotrade International). The frozen cells were freeze-substituted in acetone containing 0.25% glutaraldehyde and 0.1% uranyl acetate and embedded in Lowicryl HM20. Serial thin sections (80 nm) were cut using a Leica UCT microtome and the grids poststained with 2% aqueous uranyl acetate and Reynold's lead citrate and imaged using a Tecnai T12 microscope operating at 100 kV. SPBs were identified and ∼3--8 serial sections were imaged to capture both SPBs and the complete spindle. A total of eight *SPC29* cells and 20 *spc29-T18A* cells were imaged. For electron tomography, serial semithick (250-nm) sections were collected onto slot grids and post stained in 2% aqueous uranyl acetate and Reynold's lead citrate. Tilt series were collected using a Tecnai F30 microscope operating at 300 kV. Serial section tomograms were computed, joined, and modeled using the IMOD software package ([@B27]; [@B32]). A total of five *spc29-T18A* cells were reconstructed.

Yeast two-hybrid analysis
-------------------------

DNA-binding domain (BD) and activating domain (AD) constructs were made by amplifying genes of interest from the W303 strain genomic DNA or from plasmids containing mutant alleles using *Bam*HI and *Sal*I and ligating into pGBDU-C1(*URA3*) or pGAD-C1(*LEU2*) cleaved with the same enzymes ([@B22]). Plasmids were all sequenced to confirm correct sequence and cotransfected into PJ69-4A, *MAT***a** *trp1-901 leu2-3 leu2-112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ* ([@B22]). Colonies were selected on -Ura-Leu plates, and growth was tested on -His plates. 3-AT (3-amino-1,2,4-triazole; Sigma-Aldrich) at 5--20 mM was added to plates to reduce background growth in the Spc29AD-containing strains (in the absence of the BD plasmid to be tested).

For diagrams in [Figures 1](#F1){ref-type="fig"}[](#F2){ref-type="fig"}--[3](#F3){ref-type="fig"}, predicted coiled-coil domains were those residues with a propensity above 0.5 to be coiled--coil in 21 amino acid stretches surrounding the residue ([@B31]).
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:   differential interference contrast
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